VIST vs BMA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

VIST

37.6
AI Score
VS
BMA Wins

BMA

48.2
AI Score

Investment Advisor Scores

VIST

38score
Recommendation
AVOID NEW MONEY

BMA

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric VIST BMA Winner
Forward P/E 6.2735 3.0979 BMA
PEG Ratio 0 0.4681 Tie
Revenue Growth 83.4% 1.2% VIST
Earnings Growth -13.5% 3.5% BMA
Tradestie Score 37.6/100 48.2/100 BMA
Profit Margin 19.7% 9.0% VIST
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BMA

Relative Price Performance (Last 90 Days)

VIST 1M: -20.7% · 3M: -18.8% BMA 1M: -13.4% · 3M: -28.8%

Current Technical Phase

VIST

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 27

RSI (14): 27.2 · Price: $55.49

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.6%), weak momentum, RSI 28

RSI (14): 27.9 · Price: $55.23

Fundamentals Snapshot

Metric VIST BMA
Market Cap — —
Forward P/E 0.3 0.0
Trailing P/E 7.9 11.7
Revenue (TTM) — —
Revenue Growth 0.8% 0.0%
Gross Margin 0.8% 1.0%
Operating Margin 0.4% 0.2%
EPS 7.09 4.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.